▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3976 by analyst upside · 2026-09-28
CNMD
CONMED Corporation
Healthcare · Market Cap $1B · P/E 24.8x
ANALYST PRICE TARGET
+0.3%
implied upside to consensus target
Current Price $45.38
Consensus Target $45.5
Bull Target $49.0
Bear Target $43.0
Analysts Covering 6
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
5
Sell
1
52-Week Low $31.44
52-Week High $53.66
YTD Return +12.0%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 24.8x
Forward P/E 9.5x
EPS (TTM) $1.83
PEG Ratio 1.84
Dividend Yield 1.72%
Revenue (TTM) $1.4B
Profit Margin 4.1%
52-WEEK RANGE
52-Week Low $31.44
52-Week High $53.66
Current Price $45.38
Bear Target $43.0
Bull Target $49.0
● Now $45.38 ● Target $45.5
TRADING DATA
Avg Volume 517K
YTD Return +12.0%
Analyst Count 6
Consensus Hold
Upside to Target +0.3%
Last Updated 2026-09-28

ANALYST SUMMARY

CONMED Corporation (CNMD) is currently trading at $45.38 with a Wall Street consensus price target of $45.5, implying potential upside of 0.3% over the next 12 months. 6 analysts currently cover CNMD, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $49.0, while the most cautious has a target of $43.0.

CNMD operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 12.0% year-to-date and is currently trading near the upper end of its 52-week range of $31.44 – $53.66.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PAHC +27.7%
Phibro Animal Health Corporation
$1B · P/E 14.2x · Hold
AMN +4.6%
AMN Healthcare Services, Inc.
$1B · P/E 12.8x · Buy
HCSG +28.3%
Healthcare Services Group, Inc.
$1B · P/E 12.3x · Buy
PNTG +14.5%
The Pennant Group, Inc.
$1B · P/E 44.8x · Buy
ANIP +42.9%
ANI Pharmaceuticals, Inc.
$2B · P/E 16.1x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for CNMD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Piper Sandler reit
Neutral → Neutral 2026-07-30 14% win rate (7 calls)
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-07-30 Building track record
BMO Capital ● Initiated
Market Perform 2026-07-09 Building track record
B of A Securities ↓ Downgrade
Neutral → Underperform 2026-06-29 Building track record
B of A Securities - Reiterated
Neutral → Neutral 2026-05-18 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-05-01 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-04-30 43% win rate (7 calls)
Piper Sandler ↓ Downgrade
Overweight → Neutral 2026-03-17 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
44
out of 100
Coverage depth
15/30
Consensus clarity
27/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →